Carman Alenson

CAO & SVP, Finance at Prime Medicine

Carman Alenson is the current Chief Administrative Officer and Senior Vice President of Finance at Prime Medicine. Prior to this, they served as the Vice President of Accounting, Treasury and Tax at Agios Pharmaceuticals from 2016 to 2021. Carman has also held executive positions at AMAG Pharmaceuticals and Cubist Pharmaceuticals, and was the Senior Manager of Finance at FairPoint Communications. Alenson began their career as an Audit Senior at Ernst & Young in 1989 before becoming an Accounting Manager at Imagitas in 1994. Carman has been with Prime Medicine since October 2021.

Carmen Alenson attended the Questrom School of Business at Boston University, where they obtained their MBA. Carman also holds a BA in Economics & Business Administration from Boston University.

Some of their coworkers include Andrew Anzalone - Co-Founder & Head of Prime Editing Platform, Karen Brown - SVP, Intellectual Property and Legal Affairs, and Ann Lee - CTO. Carman Alenson reports to Keith Gottesdiener, President & CEO.

Location

Boston, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Prime Medicine

4 followers

Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of DNA. A single Prime Editor can correct the individual mutations found across patients, meaning Prime Editing can potentially address more than 90 percent of known disease-causing genetic mutations. We envision a world where this technology can cure, halt, and ultimately prevent genetic diseases, providing lifelong benefit to patients. Prime Medicine offers the opportunity to shape the future of gene editing and transform how medicines are used to treat disease. Realizing the promise of Prime Editing requires a talented team with diversity of viewpoints and expertise. We’re building a group of dedicated, scientifically curious individuals who are passionate about helping patients live longer, healthier lives.


Industries

Employees

51-200

Links